Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT(2B) receptor antagonist scaffold.
Article Details
- CitationCopy to clipboard
Kim M, Truss M, Pagare PP, Essandoh MA, Zhang Y, Williams DA
Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT(2B) receptor antagonist scaffold.
Bioorg Med Chem Lett. 2020 Nov 1;30(21):127511. doi: 10.1016/j.bmcl.2020.127511. Epub 2020 Aug 24.
- PubMed ID
- 32853682 [ View in PubMed]
- Abstract
Antagonists for the serotonin receptor 2B (5-HT(2B)) have clinical applications towards migraine, anxiety, irritable bowl syndrome, and MDMA abuse; however, few selective 5-HT(2B) antagonists have been identified. Previous studies from these labs identified a natural product, 5-hydroxy-2-(2-phenylethyl)chromone (5-HPEC, 2) as the first non-nitrogenous ligand for the 5-HT(2B) receptor. Studies on 5-HPEC optimization led to the identification of 5-hydroxy-2-(3-phenylpropyl)chromone (5-HPPC, 3), which showed a tenfold improvement in binding affinity over 2 at 5-HT(2B). This study aimed to further improve receptor pharmacology of this unique scaffold. Guided by molecular modeling studies modifications at the C-3' and C-4' positions of 3 were made to probe their effects on ligand binding affinity and efficacy. Among the derivatives synthesized 5-hydroxy-2-(3-(3-cyanophenyl)propyl)chromone (5-HCPC, 3d) showed the most promise with a multifold improvement in binding affinity (pK(i) = 7.1 +/- 0.07) over 3 with retained antagonism.